AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03374839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TIL + IL-2 + Nivolumab
Description: The patients will receive Nivolumab (at a dose of 3 mg per kilogram of body weight) every 2 weeks from day0 until week52.~Two TIL (Tumor Infiltrating Lymphocytes) injections will be performed: at week 14 and at week 18.~The TIL injections are systematically followed by subcutaneous injections of Proleukin® (IL-2) at a concentration of 6 million international unit (IU) per day for 5 days.
Study NCT01537224 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Measure of the electrophysiological activity of the subthalamic nucleus
Description: Local field recording of the subthalamic nucleus by mean of externalized electrodes in the immediate postoperative periode.
Study NCT00524927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methoxyflurane
Study NCT00524927 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Study NCT04488445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strength training
Description: 3 sets of 3 to 5 repetitions with 4 minutes of rest between sets. 90% load of 1 maximum repetition of a resistance exercise
Study NCT04488445 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Stretch and balance training
Description: 3 sets of 3 exercises of stretching and balance of one minute each. One minute of resting time between sets.
Study NCT02492802 — intervention group
Intervention type: DRUG
Intervention: posaconazole
Description: collection plasma samples for measuring posaconazole drug concentration
Study NCT00789321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Comparator: amlodipine besylate
Description: Two 5 mg tablets amlodipine daily for 6 weeks.
Study NCT00789321 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Comparator: Placebo
Description: Two 5 mg tablets placebo to amlodipine daily for 6 weeks
Study NCT03087305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Supraclavicular lymph node ultrasound
Description: Patients will have supraclavicular lymph node assessed prior to EBUS-TBNA
Study NCT02472730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Distal Attachment Cap
Description: Colonoscopies are performed under the supervision of board certified attending gastroenterologists experienced in colonoscopy. Attending physicians will provide assistance at their discretion or at the request of the trainee. All close examinations for polyps will be carried out on withdrawal of the colonoscope.
Study NCT02999789 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SmartInhaler with reminder function turned on
Description: The SmartInhaler is a medication monitoring system that functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.
Study NCT02999789 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: SmartInhaler
Description: The SmartInhaler is a medication monitoring system manufactured by Adherium that also functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.
Study NCT01394536 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Battery-operated electroacustimulation device (Inactive)
Description: In the sham arm, this device will not be turned on. The device to be used is the ReliefBand (Aeromedix, Jackson, Wy), an FDA-approved, reusable, battery-operated electroacustimulation device. The ReilefBand is a portable battery powered (lithium coin cells) device that is worn on the wrist like a watch. Two electrodes contact the skin with the aid of the application of electroconductive gel, and an electrical current of 25 mHz is transmitted through the skin. The device is applied at the Neiguan (P6) point, which is located on the inside of the wrist and is thought, in traditional Chinese medicine, to relieve nausea and vomiting (NV).
Study NCT01394536 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Battery-operated electroacustimulation device (Active)
Description: The device to be used is the ReliefBand (Aeromedix, Jackson, Wy), an FDA-approved, reusable, battery-operated electroacustimulation device. The ReilefBand is a portable battery powered (lithium coin cells) device that is worn on the wrist like a watch. Two electrodes contact the skin with the aid of the application of electroconductive gel, and an electrical current of 25 mHz is transmitted through the skin. The device is applied at the Neiguan (P6) point, which is located on the inside of the wrist and is thought, in traditional Chinese medicine, to relieve nausea and vomiting (NV).
Study NCT01827969 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ablathermy focused ultrasound
Description: ablathermy focused ultrasound
Study NCT02498678 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tetanus
Description: tetanic electric stimulation
Study NCT01837836 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health education
Description: Health education will include 1. Importance and demonstration of hygienic practices for safe drinking water 2. Promotion of water purification 3. Capacity building of community for safe water availability.
Study NCT03991390 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Feedback and Core Stability exercises protocol
Description: This arm consists of 5 sessions per week, 60 minutes each. One session consists of 30 minutes of conventional physiotherapy and 30 minutes of Core Stability exercises and laser visual feedback exercises, on alternate days.~All sessions will be performed by the same physiotherapist.
Study NCT03991390 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control stroke
Description: This arm consists of 5 sessions per week, 60 minutes each comprising usual physiotherapy treatment.~All sessions will be performed by the same physiotherapist.
Study NCT01725685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FF 400 mcg
Description: FF will be available as 100 mcg strength administered as 4 inhalations from a DPI
Study NCT01725685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UMEC 500 mcg
Description: UMEC will be available as 125 mcg strength administered as 4 inhalations from a DPI
Study NCT01725685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FF/UMEC 400/500 mcg
Description: FF/UMEC will be available as 100/125 mcg strength administered as 4 inhalations from a DPI
Study NCT02387970 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate provisionalization
Description: Stage one protocol: Individuals will receive temporary crowns at the same day as implant surgery, and a final restoration at four months after surgery.
Study NCT02387970 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Delayed provisionalization
Description: Stage two protocol: Individuals will receive temporary crowns 3 months after implant surgery, and a final restoration at four months after surgery.
Study NCT02387970 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NobelParallel CC implant
Description: Supports the comprehensive range of dental prosthetics as well as full range of prefabricated abutments.
Study NCT02828865 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irreversible Electroporation (IRE) System
Study NCT00702780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: escitalopram
Description: 5 mg/day for 2 weeks, 10 mg/day for 2 weeks and 20 mg/day for 48 weeks (maintaining donepezil at the previous stable dose during the whole trial period)
Study NCT00702780 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 5mg/day for 2 weeks, 10mg/day for 2 weeks and 20mg/day for 48 weeks (maintaining donepezil at the previous stable dose during the whole trial period)
Study NCT03788694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: 8 doses of intranasal ketamine; 40 mg per dose.
Study NCT02387970 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dental crown
Description: A tooth-shaped cap that is placed over a tooth or implant for teeth restoration and improvement in appearance.
Study NCT01669434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACEI continuation
Description: These chronic medications will be taken without interruption preoperatively.
Study NCT01669434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACEI omission
Description: Although taken chronically by patients in this intervention, the final preoperative dose of these medications will be omitted, whether it was scheduled for the morning of surgery or the day prior.
Study NCT00624793 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Standard Acup point protocol for treating nausea
Study NCT00624793 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized Acup based on TCM diagnosis
Description: Acup
Study NCT02766101 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exergaming PE Curriculum
Description: Sustained aerobic exercise.
Study NCT02766101 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard PE
Description: Non-aerobic skill building.
Study NCT00624793 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Acup
Description: Sham Acup - Non-Active
Study NCT02631005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walk With Ease
Description: Six-week walking program
Study NCT03551795 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Infusion of iNKT cells
Description: The eligible patients receive twice infusions of iNKT cells(1E8\~1E10) in one course of treatment.
Study NCT01241279 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Crystalens AO
Description: Participants will undergo small incision cataract surgery (phacoemulsification). At the time of surgery, eligible participants will be implanted bilaterally with the Crystalens AO intraocular lens.
Study NCT01241279 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoftPort LI61AO
Description: Participants will undergo small incision cataract surgery (phacoemulsification). At the time of surgery, eligible participants will be implanted bilaterally with the SoftPort LI61AO intraocular lens.
Study NCT03041441 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI algorithm
Description: MRI sequences have been developed that may be able to estimate intracranial pressure in a non-invasive fashion
Study NCT03041441 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar puncture
Description: Lumbar puncture according to the standard-of-care treatment plan.
Study NCT03041441 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epidural patching
Description: Epidural patching will be performed to the standard-of -care treatment plan
Study NCT01851941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 (folinic acid, 5-fluorouracil, and oxaliplatin )
Description: Modified FOLFOX6 regimen consists of oxaliplatin 100 mg/m2 and FA 100 mg/m2 given as a 2 hour intravenous infusion, followed by 5-FU 2.4 g/m2 given as a continuous infusion over 46 hour, which is repeated every 2 weeks. Patients receive 4 cycles of neoadjuvant modified FOLFOX6 followed by curative radical surgery with D2 dissection and 4 cycles of adjuvant modified FOLFOX6.
Study NCT00710931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR Aspheric IOL model SN6AD1
Description: Bilateral implantation of the AcrySof ReSTOR +3 Intraocular Lens (IOL) following cataract removal.
Study NCT04946812 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Split-belt treadmill training
Description: 18 sessions of SB-TM training, where the velocity of the belt will be adjusted to the over-ground speed of the subject, and will be reduced on the least affected side by 25%.
Study NCT04946812 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Split-belt treadmill training
Description: 18 sessions of SB-TM training, where the velocity of the belt will be adjusted to the over-ground speed of the subject, and will be reduced on the least affected side by 25%.
Study NCT01405560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaniprevir
Description: Capsules containing 150 mg vaniprevir, orally, two in the morning and two in the evening for 24 weeks
Study NCT01405560 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: peg-IFN
Description: Open-label peg-IFN alfa-2b at 1.5 μg/kg once per week, administered subcutaneously (SC) for 24 weeks
Study NCT01405560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ribavirin
Description: Capsules containing 200 mg RBV, orally, 3 to 5 capsules, dosage based on the participant's weight (600 mg/day to 1000 mg/day), for 24 weeks
Study NCT02267941 — intervention group
Intervention type: OTHER
Intervention: observation
Description: Data were collected by a disigned form. Statistic software was used to analyze clinical data.
Study NCT03535363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Drug: Osimertinib 80mg or 40mg
Study NCT00534027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 655
Description: AMG 655 is a monoclonal antibody directed against TR-2.
Study NCT00534027 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: AMG 655 placebo
Description: Inactive dummy AMG 655 (to maintain blind)
Study NCT04020367 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: biopsy of mucosa's olfactory
Description: intervention under general or local anesthesia
Study NCT02419599 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HE ONS
Description: High energy density, low volume oral nutritional supplement (HE ONS) in addition to appropriate nutritional management
Study NCT02419599 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SE ONS
Description: Standard energy density oral nutritional supplement (SE ONS) in addition to appropriate nutritional management
Study NCT03476421 — intervention group
Intervention type: PROCEDURE
Intervention: Hepatic resection
Description: Surgery of the liver; removal of a part of the liver
Study NCT02419807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green Solution
Description: Given subdermally
Study NCT02419807 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Technetium Tc-99m Sulfur Colloid
Description: Given via injection
Study NCT02419807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymphoscintigraphy
Description: This is a method used to check the lymph system for disease. A radioactive substance that flows through the lymph ducts and can be taken up by lymph nodes is injected into the body. A scanner or probe is used to follow the movement of this substance on a computer screen. Lymphoscintigraphy is used to find the sentinel lymph node (the first node to receive lymph from a tumor), which may be removed and checked for tumor cells. Lymphoscintigraphy is also used to diagnose certain diseases or conditions, such as lymphoma or lymphedema.
Study NCT02419807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Axillary Lymph Node Biopsy
Description: Undergo biopsy
Study NCT02507492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RM-493
Study NCT02499107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rice treatment
Description: All arms are given to all participants, in a randomized (cross over) order
Study NCT03585803 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: KMRC011 5μg or Placebo
Description: Intramuscular Injection of KMRC011 5μg or Placebo(Normal Saline) 0.1ml
Study NCT03585803 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: KMRC011 10μg or Placebo
Description: Intramuscular Injection of KMRC011 10μg or Placebo(Normal Saline) 0.2ml
Study NCT03585803 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: KMRC011 15μg or Placebo
Description: Intramuscular Injection of KMRC011 15μg or Placebo(Normal Saline) 0.3ml
Study NCT03585803 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: KMRC011 20μg or Placebo
Description: Intramuscular Injection of KMRC011 30μg or Placebo(Normal Saline) 0.4ml
Study NCT03585803 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: KMRC011 25μg or Placebo
Description: Intramuscular Injection of KMRC011 45μg or Placebo(Normal Saline) 0.5ml
Study NCT00612872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [123I]CLINDE
Description: Subjects will be injected with up to 5 mCi and not to exceed 5.5 (not >10% of 5 mCi limit) of 123-I CLINDE followed by serial SPECT imaging.
Study NCT02738853 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic Transcatheter Aortic Valve 2.0 Replacement System
Description: Treatment of severe symptomatic aortic stenosis in subjects who are considered at high through extreme risk for surgical aortic valve replacement.
Study NCT02602639 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation rowing (Odstock 4 channel neuromuscular stimulator with Concept 2 Rower)
Description: Participants will strengthen their quadriceps and hamstrings using electrical stimulation for up to 12 weeks (using an Odstock 4 channel neuromuscular stimulator). Then participants will use a seated rower (Concept 2 Rower, fitted with a backrest that allows those with spinal cord injury to engage in rowing) in conjunction with the electrical stimulation for 12-24 weeks.
Study NCT02995642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FPPRGD2
Description: One single intravenous injection.
Study NCT02995642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Positron emission tomography
Description: Undergo 18F-FPPRGD2 PET/CT or PET/MRI
Study NCT02995642 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed tomography
Description: Undergo 18F-FPPRGD2 PET/CT or PET/MRI
Study NCT02499107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pasta treatment
Study NCT02499107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Boiled and mashed potato treatment
Study NCT02995642 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo 18F-FPPRGD2 PET/CT or PET/MRI
Study NCT04270253 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conservative therapy
Description: Conservative therapy including aquatic exercises, land-based exercises, balneotherapy, TENS therapy
Study NCT04270253 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conservative therapy
Description: Conservative therapy including aquatic exercises, land-based exercises, balneotherapy, TENS therapy
Study NCT04270253 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual therapy
Description: End-range mobilization
Study NCT02811679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Blinatumomab is a bispecific t cell engaging antibody targeting CD19 and CD3 approved for B cell acute lymphoblastic leukemia
Study NCT04337541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical facial mask
Description: Participants will follow normal Authority recommendations AND wear mask outside their homes, or when receiving visits in their home.
Study NCT01099475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pringle manoeuvre 15 minutes
Description: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Study NCT01099475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pringle manoeuvre 30 minutes
Description: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Study NCT02627053 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rivaroxaban
Study NCT03772587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M281
Description: M281 administered as IV infusion
Study NCT03772587 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as intravenous (IV) infusion
Study NCT03311464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adalimumab
Description: Study drug will be administered subcutaneously.
Study NCT01472458 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Quality improvement
Description: The primary intervention in this project will be a multi-faceted quality improvement plan targeting improved predictions of neurological outcome and survival after cardiac arrest.
Study NCT03464851 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid Stenotic Scan (CSS)
Description: Placement of the CSS instrument on the carotid arteries to measure degree of stenosis~of the carotid artery. The CSS scan takes about 1-2 minutes to gather data for real-time analysis by the processor on the device cart.
Study NCT02499107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Baked french fries treatment
Study NCT02499107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fried french fries treatment
Study NCT02539992 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Triathlon® CR/Kinematic Alignment
Description: Total knee replacement using patient-specific cutting guides